外周血管介入治疗大咯血的临床疗效探讨

Clinical Curative Efficacy of Peripheral Vascular Intervention for the Treatment of Massive Hemoptysis

目的观察和探讨外周血管介入治疗大咯血的临床疗效。方法整群选择于2014年8月—2015年5月该院收治的治疗大咯血的64例患者做为研究对象,随机分为两组,观察组和对照组,每组32例患者。观察组患者行外周血管介入治疗,对照组患者行常规治疗,观察对比两组患者的临床疗效,不良反应及复发率。结果观察组的临床有效率为93.75%,对照组为68.75%,观察组的临床有效率显著优于对照组,并且差异具有统计学意义(P<0.5);观察组的不良反应发生率为12.5%,对照组为40.625%,观察组显著优于对照组,并且差异具有统计学意义(P<0.05);随访3个月后,观察组有2例复发,复发率为6.25%;对照组有9例复发,复发率为28.125%,观察组患者显著低于对照组患者,并且差异具有统计学意义(P<0.05)。结论外周血管介入治疗大咯血,临床疗效显著,不良反应少,复发率低,值得临床推广应用。

Objective To observe and discuss the clinical curative efficacy of peripheral vascular intervention for the treatment of massive hemoptysis. Methods We selected 64 cases of patients who were treated for massive hemoptysis from 2014 August to2015 Mayr in our hospital as the research subjects, and they were randomly divided into two groups, with 32 in each group. The observation group was treated with peripheral vascular interventional treatment, while the patients in the control group received routine treatment. The clinical curative effect, the recurrence rate and adverse reactions of two groups were compared. Results The clinical effective rate was 93.75% in the observation group and 68.75% in the control group, the former was significantly higher than the latter with statistical difference(P<0.5); the adverse reaction rate was 12.5% in the observation group and 40.625% in the control group, and the difference was statistically significant, P<0.05; after three months of follow-up, the observation group had 2cases of recurrence, and the recurrence rate was 6.25%, while the control group had 9 cases of recurrence, and the recurrence rate was 28.125%, and there was statistically significant difference between them(P<0.05). Conclusion Peripheral vascular interventional for the treatment of massive hemoptysis has higher clinical curative effect, less adverse reaction and lower recurrence rate, therefore it is worthy of clinical application.